Skip to main content

XPONANCE LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1637541 PHILADELPHIA, PA

Position in REGN

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$11,263,003
-$2,654,561 QoQ
Shares Held
18,063
+0.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#272
of 1,297 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

XPONANCE LLC holds $117,820,260 across 121 Biotechnology names. REGN ranks #2 (9.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
18,063 $11,263,003

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,263,003 18,063
2026-03-31 $13,917,564 18,013
2025-12-31 $12,068,959 15,636
2025-09-30 $8,588,111 15,274
2025-06-30 $8,329,125 15,865
2025-03-31 $10,317,019 16,267
2024-12-31 $11,591,033 16,272
2024-09-30 $16,599,079 15,790
2024-06-30 $16,292,016 15,501
2024-03-31 $14,946,507 15,529
2023-12-31 $12,626,297 14,376
2023-09-30 $11,129,711 13,524
2023-06-30 $10,480,624 14,586
2023-03-31 $12,638,106 15,381
2022-12-31 $10,785,554 14,949
2022-09-30 $8,907,777 12,931
2022-06-30 $7,347,154 12,429
2022-03-31 $9,360,224 13,402
2021-12-31 $8,336,064 13,200
2021-09-30 $3,850,155 6,362
2021-06-30 $3,811,476 6,824
2021-03-31 $6,886,552 14,555
2020-12-31 $7,050,990 14,595
2020-09-30 $12,125,954 21,662
2020-06-30 $14,439,368 23,153